Royalty Pharma (RPRX) Assets (2019 - 2026)
Royalty Pharma's Assets came in at $19.82 billion for Q2 2026, up 8.2% from $18.32 billion a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Royalty Pharma (RPRX) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Royalty Pharma's Assets was $19.62 billion, up 7.7% from FY2024.
- Assets carries a five-year compound annual growth rate of 4.1% (FY2020 to FY2025).
- Going back by year, Assets was $18.22 billion in FY2024 (+11.2%), $16.38 billion in FY2023 (-2.6%), $16.81 billion in FY2022 (-4.0%) and $17.52 billion in FY2021 (+9.3%).
- The Q2 2026 figure represents the highest quarterly Assets in data going back to Q4 2019.
- Year-over-year, Assets has increased for nine consecutive quarters, with growth averaging 9.2% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q3 2024 (growth of 13.8%), and the weakest in Q3 2023 (a decline of 10.3%).
- Business Quant data shows RPRX's Assets at $19.82 billion (Q1 2026), $19.62 billion (Q4 2025) and $19.35 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 43.85 Bn | 44.35 Bn | - | 114.54 Bn |
| 2 | Rocket Companies | 43.67 Bn | 29.35 Bn | - | 60.98 Bn |
| 3 | Royalty Pharma | 33.56 Bn | 33.48 Bn | - | 19.82 Bn |
| 4 | Federal National Mortgage Association Fannie Mae | 25.52 Bn | 25.52 Bn | - | 4,332.34 Bn |
| 5 | Synchrony Financial | 23.24 Bn | -44.73 Bn | - | 121.93 Bn |
| 6 | Affirm Holdings | 22.66 Bn | 16.35 Bn | - | 15.79 Bn |
| 7 | Royal Gold | 20.35 Bn | 19.57 Bn | 390.45 Mn | 9.45 Bn |
| 8 | Annaly Capital Management | 15.27 Bn | 6.37 Bn | - | 143.74 Bn |
| 9 | Ares Capital | 13.74 Bn | 11.17 Bn | - | 30.50 Bn |
| 10 | Federal Home Loan Mortgage | 12.68 Bn | -6.06 Bn | - | 3,518.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.82 Bn |
| Mar 31, 2026 | 19.82 Bn |
| Dec 31, 2025 | 19.62 Bn |
| Sep 30, 2025 | 19.35 Bn |
| Jun 30, 2025 | 18.32 Bn |
| Mar 31, 2025 | 17.61 Bn |
| Dec 31, 2024 | 18.22 Bn |
| Sep 30, 2024 | 18.04 Bn |
| Jun 30, 2024 | 17.66 Bn |
| Mar 31, 2024 | 16.13 Bn |
| Dec 31, 2023 | 16.38 Bn |
| Sep 30, 2023 | 15.86 Bn |
| Jun 30, 2023 | 17.12 Bn |
| Mar 31, 2023 | 17.07 Bn |
| Dec 31, 2022 | 16.81 Bn |
| Sep 30, 2022 | 17.67 Bn |
| Jun 30, 2022 | 17.74 Bn |
| Mar 31, 2022 | 17.38 Bn |
| Dec 31, 2021 | 17.52 Bn |
| Sep 30, 2021 | 17.73 Bn |
API Access
Royalty Pharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=RPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "RPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=RPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();